NYSE$PHR
Phreesia Inc · Q3 2021 earnings
Q3 2021 earnings · · Investor relations
Briefing
Announced fiscal third quarter 2021 results with revenue increasing by 17% year-over-year.
Phreesia reported revenue of $38.5 million for the fiscal third quarter ended October 31, 2020, representing a 17% increase compared to the same period in the prior year. The average number of provider clients increased by 10% to 1,737, and the average revenue per provider client increased by 5% to $17,490. Adjusted EBITDA was positive $1.2 million. Cash and cash equivalents totaled $254.1 million.
- Revenue was $38.5 million, up 17% year-over-year.
- Average provider clients were 1,737, a 10% increase year-over-year.
- Average revenue per provider client was $17,490, up 5% year-over-year.
- Adjusted EBITDA was positive $1.2 million.
Headline financials
Revenue & EPS history
Phreesia · Revenue · Quarterly
$38.5M
Revenue by segment
Phreesia · $30.4M total across 2 segments · Q3 2021
- Subscription Services$17.5M—57.5%
- Payment Processing$12.9M—42.5%
Forward guidance
For the full fiscal year 2021, ending January 31, 2021, the Company expects to report revenue of $146 to $147 million. For the full fiscal year 2022, ending January 31, 2022, the Company expects revenue to grow between 20 and 25 percent over fiscal year 2021.
Tailwinds
- Revenue of $146 to $147 million expected for fiscal year 2021.
- Revenue growth of 20 to 25 percent expected for fiscal year 2022 over fiscal year 2021.
Headwinds
- Uncertainty regarding the impact of the COVID-19 pandemic on business operations, financial performance, and results of operations.
- Potential impact from surges of COVID-19 cases and additional restrictions on patient visits.
- Disruptions to provider operations may impact subscription and related services revenue.
- Decline in non-essential and elective patient visits may impact revenue from payment processing tools.
- Decline in patient visits may impact revenue earned through patient engagement in life sciences.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q3 2021
-1.6%
Avg return
Earnings day
+2.5%
Avg return
5 days after
+2.0%
Avg return
30 days after
54%
15 / 28 earnings
Positive
+21.4%
Q2 2023
Best reaction
-26.3%
Q4 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -26.3% | -1.1% | — | |
| Q1 2027 | +2.3% | +13.3% | — | |
| Q3 2026 | -22.8% | -19.2% | -16.0% | |
| Q2 2026 | -9.8% | -18.8% | -25.4% | |
| Q1 2026 | -6.6% | -0.2% | +14.2% | |
| Q4 2025 | +6.9% | +14.6% | +1.1% | |
| Q3 2025 | +11.1% | +14.8% | +30.8% | |
| Q2 2025 | +7.9% | +0.5% | -6.8% | |
| Q1 2025 | -13.3% | -14.7% | -2.9% | |
| Q4 2024 | +1.7% | -0.7% | +1.0% | |
| Q3 2024 | +17.8% | +18.8% | +45.2% | |
| Q2 2024 | -21.2% | -27.1% | -39.1% | |
| Q1 2024 | +3.6% | +10.3% | +4.0% | |
| Q4 2023 | -13.5% | -10.0% | -5.7% | |
| Q3 2023 | +18.7% | +34.8% | +20.0% | |
| Q2 2023 | +21.4% | +28.2% | +4.9% | |
| Q1 2023 | +11.9% | +17.5% | +40.1% | |
| Q4 2022 | -11.9% | +1.3% | -23.6% | |
| Q3 2022 | -20.2% | -20.9% | -32.9% | |
| Q2 2022 | -12.4% | -6.2% | -15.4% | |
| Q1 2022 | +6.6% | +12.7% | +24.2% | |
| Q4 2021 | +2.5% | +8.4% | +3.3% | |
| Q3 2021 | +7.3% | +18.1% | +16.2% | |
| Q2 2021 | -3.2% | -9.2% | +3.5% | |
| Q1 2021 | -6.7% | -10.5% | -13.1% | |
| Q4 2020 | +4.2% | +18.1% | +30.6% | |
| Q3 2020 | -1.0% | -8.8% | -6.9% | |
| Q2 2020 | +0.2% | +7.3% | +1.2% | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro